Self Selection Trial of Naproxen Sodium (KEIFER SST) - Trial 2014-005305-20
Access comprehensive clinical trial information for 2014-005305-20 through Pure Global AI's free database. This Phase 3 trial is sponsored by Bayer HealthCare AG and is currently status unknown. The study focuses on Pain.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2014-005305-20
Phase 3
Trial Details
EU Clinical Trials Register • 2014-005305-20
Self Selection Trial of Naproxen Sodium (KEIFER SST)
Study Focus
Sponsor & Location
Bayer HealthCare AG
Timeline & Enrollment
Phase 3
N/A
N/A
Primary Outcome
The Percentage of Participants Who Selected Naproxen Sodium ER and Expected Their Pain to Last More Than 12 Hours
ICD-10 Classifications
Pain, unspecified
Pain, not elsewhere classified
Pain in limb
Acute pain
Other chronic pain
Data Source
EU Clinical Trials Register
2014-005305-20
Non-Device Trial